Clinical Trial

The Role of Circadian Factors in Regulation of Neuroplasticity in Ischemic Stroke (Observational)

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 8, 2025 (before its estimated January 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The study is aimed at the investigation of the association of biomarkers of circadian rhythms with sleep characteristics and stroke outcome in acute stroke patients. It is designed as an observational cohort study with the retrospective and prospective longitudinal arms.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-02-05; most recent amendment 2025-08-05.
Trial Details
NCT Number NCT05242393
Lead Sponsor Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
Conditions Stroke, Ischemic, Sleep Disorder
Enrollment 250 participants
Start Date 2018-05-01
Primary Completion 2026-01-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-08